Bristol-Myers Squibb Company
MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING
Last updated:
Abstract:
Compounds represented by formula (I) ##STR00001## can be used to make antibody-drug conjugates. The conjugates so made are stable in both human and mouse serum, enabling the performance of pre-clinical studies using a mouse model.
Status:
Application
Type:
Utility
Filling date:
29 May 2019
Issue date:
5 Dec 2019